Advertisements

Stocking Stuffers

 

Geron Corporation (GERN) Stock Quote

Detailed Quote for Geron Corporation (GERN)
$ 1.47   -0.03 (-2.00%) Volume: 1.52m 4:00 PM EST Dec 11, 2019
After Hours:  $ 1.46   -0.01 (-0.68%) Volume: 2.8k 7:41 PM EST Dec 11, 2019
Today 5d 1m 3m 1y more
Last Price
1.47
Change $
0.03
Change %
2.00%
Tick
  
Bid
1.48
Bid Size
100
Ask
1.49
Ask Size
1,100
Open
1.50
High
1.51
Low
1.45
Prev Close
1.50
Last Trade
12/11/19
Volume
1.52m
52 Wk Hi
2.1400001
52 Wk Low
0.954699993
Market Cap
293.67m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
199,777,619
EPS (TTM)
-0.25
PE Ratio
N/A
Exchange
NGS
News and Media for Geron Corporation (GERN)
Sector News | Topic News
News for Geron Corporation (GERN)
Tue, Dec 10, 2019
9:15 AM Geron Reports Two Poster Presentations at American Society of Hematology Annual Meeting - Business Wire
Sun, Dec 08, 2019
12:09 PM Penny Stocks On Robinhood To Watch This Week Presenting Key Data - PennyStocks.com
Tue, Dec 03, 2019
8:00 AM Geron Announces Appointment of New Executive to Focus on Corporate Strategy - Business Wire
Thu, Nov 21, 2019
8:00 AM Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Tue, Nov 19, 2019
8:12 AM Evercore downgrades bluebird bio and Clovis in premarket analyst action - SeekingAlpha
Wed, Nov 13, 2019
7:27 AM Geron: A Different Company - SeekingAlpha
Tue, Nov 12, 2019
3:42 PM Geron: Hold Despite Slim Premium As Promising Trials Await Funding - SeekingAlpha
Fri, Nov 08, 2019
8:00 AM Geron Corporation (Delaware) (GERN) Q3 2019 Earnings Call Transcript - Motley Fool
Thu, Nov 07, 2019
5:48 PM Geron Corporation (GERN) CEO John Scarlett on Q3 2019 Results - Earnings Call Transcript - SeekingAlpha
Wed, Nov 06, 2019
4:15 PM Geron EPS beats by $0.07, beats on revenue - SeekingAlpha
4:10 PM Geron Corporation Reports Third Quarter 2019 Financial Results and Recent Events - GlobeNewswire
9:18 AM Geron Announces Two Poster Presentations at Upcoming American Society of Hematology Annual Meeting - GlobeNewswire
Thu, Oct 31, 2019
8:00 AM Geron to Announce Third Quarter Financial Results on November 6, 2019 - GlobeNewswire
Tue, Oct 29, 2019
7:00 AM Geron (GERN) Alert: Johnson Fistel Launches Investigation into Geron Corporation; Investors Encouraged to Contact Firm - PR Newswire
Sat, Oct 19, 2019
12:15 PM Better Buy: Geron vs. Celgene - Motley Fool
Thu, Oct 17, 2019
4:10 PM Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
More News for GERN >>
Filings for Geron Corporation (GERN)
Wed, Dec 04, 2019
3:00 AM Initial statement of beneficial ownership of securities - Form 3
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Wed, Nov 06, 2019
3:00 AM Current report pursuant to Section 13 or 15(d) - Form 8-K
3:00 AM General form for quarterly reports under Section 13 or 15(d) - Form 10-Q
More Filings for GERN >>

Tags for Geron Corporation

Research stocks or mutual funds related to Geron Corporation by keywords or tags. Find companies that have a similar focus to GERN. The keywords below have been associated to GERN by either user submission or electronic means.

stem cell research ethical stem cells information cell definition stem cell embryonic stem history of embryonic stem cell research for stem cell research cloning stem cells cell cloning research stem stem cell research con stem cell research paper stem cell treatments facts on stem cell research debate over stem cell research umbilical stem cells stem cell injections embryonic stem cells stem cells controversy against stem cells embryo stem cell research cell debate research stem benefits of stem cell research human cell cord stem cell bank cord blood stem cell research stem cell research and cloning define stem cell research stem cell research foundation stem cell collection cell pluripotent stem embryonic stem cells research stem cell research and diabetes embryo stem cell stem cell research articles for stem cell research cell mesenchymal stem stem cell bill stem cells therapy biotechnology research opposing stem cell research Drugs neural stem cells cell company stem stem cell therapy cancer pluripotent stem cells stem cell benefits of embryonic stem cell research anti stem cell research future of stem cell research stem cell research bill stem cell research funding

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2019 InvestorPoint.com All rights reserved.